Clinical trials
No Disease or Condition is Being Studied clinical trials
Below are recruiting no disease or condition is being studied clinical trials, each written for real people, not researchers. We’re tracking 18,483 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04847752Recruiting
Predicting outcomes after stroke from artery plaque
This study looks at factors that can help predict recovery and risk after an ischemic stroke caused by plaque buildup in a major artery. It may help doctors better forecast prognosis and tailor follow-up care for people like you.
WuhanAges Up to 80 years - NCT06466018Recruiting
Eye disorder biomarkers study for European adults
This study looks for new ways to diagnose and track eye disorders using imaging and genetic tests. It may help find better treatments for conditions linked to blood vessel and nerve problems in the eye.
ParisAges 18 years+ - NCT06467786RecruitingPhase 4
Irinotecan liposomes for advanced small cell lung cancer
This trial is testing a new form of chemotherapy called irinotecan liposomes for people with advanced small cell lung cancer that has worsened after initial treatment. It aims to see if this drug can shrink tumors and improve survival.
Xi'an, ShannxiAges 18 years+ - NCT06467500RecruitingPhase 2
Cadonilimab plus chemo for lung cancer after immunotherapy
This trial tests a new drug called cadonilimab combined with chemotherapy for people with advanced lung cancer who have already tried and failed immunotherapy. It aims to see if this combination can help when standard immunotherapy no longer works.
YichangAges 18–75 - NCT07832552Enrolling by invitationPhase 3
Eye drop treatment for pain and swelling after cataract surgery
This study tests a medication given as an injection during cataract surgery to prevent eye pain and swelling. It aims to see if it helps you recover more comfortably.
Kansas City, MissouriAges 18 years+ - NCT07831213Recruiting
Safety and performance study of a lip filler
This study is testing a new lip filler to see if it works well and is safe. It may help people who want to improve the look of their lips.
Lod, IsraelAges 18 years+ - NCT07826689RecruitingPhase 1/Phase 2
Oral pill for relapsing multiple sclerosis
This study tests an experimental oral drug, PRO-1562, in two parts: first in healthy volunteers to check safety, then in people with relapsing multiple sclerosis to see if it can reduce disease activity. It may offer a new, convenient treatment option.
Adelaide, South AustraliaAges 18–65 - NCT07833852Enrolling by invitation
Long-term protection study for bivalent HPV vaccine
This study follows up with people who received the bivalent HPV vaccine to see how long their protection lasts and whether any breakthrough infections occur. It involves extra blood tests or follow-up visits over several years.
Mianyang, SichuanAges 12–34 - NCT07827014Recruiting
Protein shake study for healthy adults
This study tests a daily protein shake in two flavors to see how well people tolerate it and if it affects their well-being. You would drink it once a day for 15 days and answer some questionnaires.
Carlsbad, CaliforniaAges 21–65 - NCT07830550Enrolling by invitation
Blood donation study for a syphilis test
This study is collecting blood samples from healthy adults to help develop a new test for syphilis, an infection that can be spread through sex. If you are willing to give a small blood sample, you may be able to join and help improve testing.
Salem, New HampshireAges 22 years+ - NCT07832292RecruitingPhase 2
Study of an investigational drug for metastatic prostate cancer
This trial tests an experimental drug (JNJ-101556143) for men with metastatic prostate cancer that has stopped responding to hormone therapy. The goal is to see if this drug can slow down or stop the cancer from growing.
Lafayette, LouisianaAges 18 years+ - NCT07827586Recruiting
Ocrelizumab injection for relapsing-remitting multiple sclerosis
This study looks at how well the injected form of ocrelizumab works for people with relapsing-remitting multiple sclerosis (RRMS) in everyday care. It aims to understand the treatment's effects and side effects outside of a clinical trial setting.
LjubljanaAges 18 years+ - NCT07830342RecruitingPhase 1
Study of tumor-infiltrating lymphocyte therapy for advanced non-small cell lung cancer
This trial tests a new cell therapy that uses your own immune cells (TILs) to fight lung cancer. If you have advanced non-small cell lung cancer and standard treatments haven't worked, this treatment might help your immune system attack the cancer more effectively.
ShanghaiAges 18–75 - NCT05877391Recruiting
Collecting sexual and gender identity information in hospice
This study tests an approach to collect and use sexual orientation and gender identity (often called “SOGI”) information for people receiving hospice care. The goal is to help hospice teams better understand and support patients’ needs.
Aurora, ColoradoAges 18 years+ - NCT06463717Recruiting
Stem cell transplant timing for multiple myeloma with no cancer cells left
This trial looks at people with newly diagnosed multiple myeloma who have no detectable cancer cells after initial treatment. It aims to see if these patients can do well without a stem cell transplant or with a delayed one, reducing unnecessary side effects.
Hangzhou, ZhejiangAges 18–70 - NCT05532696RecruitingPhase 1/Phase 2
Testing ABT-101 for advanced solid tumors and HER2-mutant lung cancer
This study tests ABT-101, a new experimental treatment, in people with advanced solid tumors. A second part specifically looks at people with non-small cell lung cancer (NSCLC) that has HER2 mutations, to see how well the treatment works and how safe it is.
TaichungAges 18 years+ - NCT06341335RecruitingPhase 3
AK104 and AK109 plus paclitaxel for advanced stomach cancer
This trial tests a combination of two experimental immunotherapies (AK104 and AK109) with a standard chemo drug (paclitaxel) for people with advanced stomach or gastroesophageal junction cancer that has grown after initial treatment. The goal is to see if this new combination can help shrink tumors or slow the cancer better than chemo alone.
BeijingAges 18–75 - NCT07826741Recruiting
Pain relief options for open inguinal hernia surgery
This study compares two ways to manage pain after open inguinal hernia repair: a spinal injection of morphine and a numbing injection near the abdomen. The goal is to find which method provides better pain relief with fewer side effects.
Yenimahalle, AnkaraAges 18–80 - NCT07827989Recruiting
Study of phosphate supplements on hormone levels in low blood phosphate
This study looks at how giving phosphate supplements affects a hormone called FGF23 in patients with low blood phosphate levels. It aims to help understand how the body responds to treatment.
Clermont-FerrandAges 18 years+ - NCT07833410Recruiting
Study of brain bleeding recovery with Chinese hospitals
This study looks at people who have had a brain bleed (intracerebral hemorrhage) to learn more about their recovery over time. It does not involve a new treatment but rather follows participants to understand the condition better.
Changsha, HunanAges 18 years+ - NCT07832188Recruiting
Brain stimulation for chronic lower back pain
This study tests a non-invasive brain stimulation technique that uses gentle electrical currents to target the part of the brain involved in pain processing. It may help reduce chronic lower back pain that is not caused by a specific injury or condition.
Jinan, ShandongAges 18–80 - NCT07831876RecruitingPhase 1
Ear nerve stimulation for eye inflammation
This study tests whether gently stimulating a nerve in the ear can help reduce swelling or irritation in the eyes. It may offer a new drug-free way to treat certain types of eye inflammation.
Basking Ridge, New JerseyAges 18 years+ - NCT07831681Recruiting
A therapeutic game for teens with psychotic symptoms
This trial tests whether a collaborative video game can help reduce psychiatric symptoms like delusions and hallucinations in teenagers. It may also help with rigid thinking, and could be a new way to support mental health during outpatient care.
RennesAges 12–17 - NCT07829276Enrolling by invitation
Preventing low white blood cell fever during cancer chemotherapy
This study compares different doses of a medication called PEG-rhG-CSF, which is used to help prevent a serious side effect of chemotherapy called febrile neutropenia (fever with a low white blood cell count). The goal is to find the best dose that keeps your blood counts healthy and reduces the risk of infection during treatment.
Hangzhou, ZhejiangAges 18–75
Hear when a new No Disease or Condition is Being Studied trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for no disease or condition is being studied?
- Yes. Clin2 currently lists 18,483 recruiting no disease or condition is being studied studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a no disease or condition is being studied trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a no disease or condition is being studied trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.